Advertisement

Ads Placeholder
Loading...

Apontis Pharma AG

APPH.DE•XETRA
Healthcare
Drug Manufacturers - Specialty & Generic
€11.00
€0.00(0.00%)
German Market opens in 1h 15m

Apontis Pharma AG (APPH.DE) Stock Overview

Explore Apontis Pharma AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap91.6M
P/E Ratio140.00
EPS (TTM)$0.08
ROE0.02%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$15.84

APPH.DE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Apontis Pharma AG (APPH.DE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 58.47, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $15.84.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 140.00 and a market capitalization of 91.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
1.85%
6-Month Change
1.85%
Year-to-Date (YTD) Change
9.45%
1-Year Change
9.45%
3-Year Change
26.15%
5-Year Change
-41.33%
All-Time (Max) Change
-41.33%

Contact Information

https://apontis-pharma.de
49 2173 8955 4949
Alfred-Nobel-Str. 10, Monheim am Rhein, NaN, 40789

Company Facts

1,370 Employees
IPO DateMay 11, 2021
CountryDE

Frequently Asked Questions